HOMOCYSTEINЕ AFTER LIVER TRANSPLANTATION IN CHILDREN
https://doi.org/10.15825/1995-1191-2012-4-44-47
Abstract
The research plasma levels of homocysteine (Hcy) in 99 children with congenital and hereditary diseases of hepatobiliary system was performed before liver transplantation. 27% of patients had hyperhomocysteinemia. There was correlation between Hcy levels and sCD40L. High (≥5.1 μmol/L) pretransplant concentration of Hcy is one of the negative factors that affect function of the liver graft in the early post-transplant period.
About the Authors
O. P. ShevchenkoRussian Federation
V. V. Dolgov
O. E. Gichkun
N. V. Kuncevich
O. M Tsirulnikova
S. V. Gautier
References
1. Шевченко О.П. Гомоцистеин и его роль в клиниче- ской практике // Клиническая лабораторная диагно- стика. 2008. No 11. С. 25–32.
2. Шевченко О.П., Орлова О.В., Казаков Э.Н. и др. Кли- ническое значение растворимого лиганда CD40 у ре- ципиентов сердца // Вестник транспл. и искусств. ор- ганов. 2009. No 1. С. 40–45.
3. Шевченко О.П., Цирульникова О.М., Гичкун О.Е. и др. Прогностическое значение растворимой фор- мы лиганда CD40 при трансплантации печени детям с врожденными и наследственными заболеваниями гепатобилиарной системы // Вестник транспл. и ис-
4. кусств. органов. 2012. No 2. С. 15–19.
5. Akoglu B., Wondra K., Caspary W.F., Faust D. Deter-
6. minants of fasting total serum homocysteine levels in liver transplant recipients // Exp. Clin. Transplant. 2006. Vol. 4 (1). P. 462–466.
7. Akoglu B., Schrott M., Bolouri H. et al. The folic acid metabolite L-5-methyltetrahydrofolate effectively re- duces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study // Eur. J. Clin. Nutr. 2008. Vol. 62 (6). P. 796–801.
8. Bianchi G., Nicolino F., Passerini G. et al. Plasma total homocysteine and cardiovascular risk in patients sub- mitted to liver transplantation // Liver transplantation. 2006. Vol. 12. P. 105–111.
9. Bosy-Westphal A., Ruschmeyer M., Czech N. et al. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotropic liver transplantation // Am. J. Clin. Nutr. 2003. Vol. 77 (5). P. 1269–1277.
10. Fernández-Miranda C., Sanz M., de la Calle A. Deter- minants of increased plasma homocysteine in 221 sta- ble liver transplant patients // Clinical Chemistry. 2001. Vol. 47. P. 2037–2040.
11. Gaweco A.S., Wiesner R.H., Yong S. et al. CD40L (CD154) expression in Human liver allograft during chronic ductopenic rejection // Liver transplantation and surgery. 1999. Vol. 5. No 1. P. 1–7.
12. Look M.P., Riezier R., Reichel C. et al. Is the increase in serum cystationine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfurati- on at level of gamma-cystathionase? // Scand. J. Gastro- enterol. 2000. Vol. 35. P. 866–872.
13. Prontera C., Martelli N., Evangelista V. et al. Homo- cysteine modulates the CD40/CD40L system // J. Am. Coll. Cardiol. 2007. Vol. 49 (22). P. 2182–2190.
14. Van Kooten C., Banchereau J. CD40-CD40 ligand // J. of Leukocyte biology. 2000. Vol. 67. P. 2–17.
Review
For citations:
Shevchenko O.P., Dolgov V.V., Gichkun O.E., Kuncevich N.V., Tsirulnikova O.M., Gautier S.V. HOMOCYSTEINЕ AFTER LIVER TRANSPLANTATION IN CHILDREN. Russian Journal of Transplantology and Artificial Organs. 2012;14(4):44-47. (In Russ.) https://doi.org/10.15825/1995-1191-2012-4-44-47